Combination treatment with lamivudine plus interleukin-12 shows greater antiviral activity in chronic hepatitis B.

被引：0
|
作者：
Naoumov, NV
Suri, D
Rigopoulou, EI
Machell, T
Mullerova, I
Chokshi, S
Rice, S
Tedder, RS
Williams, R
机构：
[1] UCL, Inst Hepatol, London, England
[2] UCL, Dept Virol, London, England
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
868
引用
收藏
页码：376A / 376A
页数：1
相关论文
共 50 条
  • [41] A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
    Carreño, V
    Zeuzem, S
    Hopf, U
    Marcellin, P
    Cooksley, WGE
    Fevery, J
    Diago, M
    Reddy, R
    Peters, M
    Rittweger, K
    Rakhit, A
    Pardo, M
    JOURNAL OF HEPATOLOGY, 2000, 32 (02) : 317 - 324
  • [42] Rescue Therapy for Lamivudine-resistant Chronic Hepatitis B: Adefovir Monotherapy, Adefovir Plus Lamivudine or Entecavir Combination Therapy
    Ha, Minghao
    Zhang, Guotong
    Diao, Shu
    Lin, Mingfang
    Wu, Jianqiu
    Sun, Liping
    She, Huiyuan
    Shen, Lihui
    Huang, Chunhong
    Shen, Wenjuan
    Huang, Zhongming
    INTERNAL MEDICINE, 2012, 51 (12) : 1509 - 1515
  • [43] Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy
    Schvoerer, E
    Navas, MC
    Thumann, C
    Fuchs, A
    Meyer, N
    Habersetzer, F
    Stoll-Keller, F
    JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (04) : 588 - 593
  • [44] Efficacy of Combination Tenofovir Plus Lamivudine Versus Tenofovir Monotherapy in Patients With Chronic Hepatitis B Virus
    Glyn, Frederick J.
    Gill, Upkar
    Alazawi, William
    Ross, Valerie
    Kooner, Paul
    Marley, Richard
    Foster, Graham
    Kennedy, Patrick T.
    GASTROENTEROLOGY, 2011, 140 (05) : S455 - S455
  • [45] EFFICACY OF COMBINATION TENOFOVIR PLUS LAMIVUDINE VERSUS TENOFOVIR MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS
    Glyn, F.
    Gill, U. S.
    Alazawi, W.
    Ross, V.
    Kooner, P.
    Marley, R.
    Foster, G. R.
    Kennedy, P. T. F.
    GUT, 2011, 60 : A231 - A231
  • [46] Efavirenz in combination with n-acetyl cysteine shows improved outcome in treatment of hepatitis B.
    Liu, Lili
    Chen, Longyan
    Li, Fuhai
    Zhang, Yan
    Yang, Jie
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (08): : 3362 - 3368
  • [47] Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
    Wang, Zhao
    Wu, Xiao-Ling
    Zeng, Wei-Zheng
    Xu, Hui
    Zhang, Yong
    Qin, Jian-Ping
    Jiang, Ming-De
    VIROLOGY JOURNAL, 2011, 8
  • [48] Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
    Zhao Wang
    Xiao-Ling Wu
    Wei-Zheng Zeng
    Hui Xu
    Yong Zhang
    Jian-Ping Qin
    Ming-De Jiang
    Virology Journal, 8
  • [49] Treatment of HBeAg (-) chronic hepatitis B with lamivudine vs. lamivudine plus interferon:: A randomized controlled clinical trial
    Yurdaydin, C
    Bozkaya, H
    Çetinkaya, H
    Sasmaz, N
    Sahin, T
    Altin, H
    Oguz, D
    Turkyilmaz, AR
    Erkan, Ö
    Bozdayi, AM
    Uzunalimoglu, Ö
    JOURNAL OF HEPATOLOGY, 2001, 34 : 163 - 163
  • [50] Cost effectiveness and budget impact of lamivudine antiviral treatment for chronic hepatitis type B patients in Taiwan
    Shau, WY
    Tsai, IC
    Scuffham, PA
    Dziekan, KX
    VALUE IN HEALTH, 2005, 8 (06) : A118 - A119
12345